Mayo Clinic - Q1 2021 holdings

$86.9 Billion is the total value of Mayo Clinic's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .

 Value Shares↓ Weighting
BSM  BLACK STONE MINERALSbsm$49,877,737,000
+130439.2%
5,719,9240.0%57.42%
+24.9%
ZNTL  Zentalis Pharmaceuticals Inczntl$15,727,096,000
+83439.2%
362,4590.0%18.11%
-20.1%
UBX  UNITY BIOTECHNOLOGY INCubx$9,431,886,000
+114406.3%
1,571,9810.0%10.86%
+9.6%
BSGM  BIOSIG TECH INCbsgm$434,840,000
+110546.3%
100,8910.0%0.50%
+5.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BLACK STONE MINERALS11Q3 202382.2%
Evelo Bioseciences Inc11Q3 20237.3%
BIOSIG TECH INC10Q2 20236.7%
Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC)10Q3 20233.5%
Zentalis Pharmaceuticals Inc9Q3 202322.6%
UNITY BIOTECHNOLOGY INC8Q4 202223.1%
EXACT SCIENCES CORP7Q2 20234.5%
Neuroon Medical Technologies5Q3 20231.3%
MSCI ACWI ETF4Q3 202389.6%
Sorrento Therapeutics4Q4 20226.1%

View Mayo Clinic's complete holdings history.

Latest significant ownerships (13-D/G)
Mayo Clinic Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VENTURE LENDING & LEASING IV INCMarch 16, 20056,0006.0%

View Mayo Clinic's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-13
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-09
13F-HR2023-05-05
13F-HR/A2023-02-09
13F-HR2023-01-26
13F-HR2021-08-12
13F-HR2021-05-13
13F-HR2021-02-11

View Mayo Clinic's complete filings history.

Compare quarters

Export Mayo Clinic's holdings